Sanofi provides update on Phase 2 study evaluating amcenestrant in ER+/HER2- advanced or metastatic breast cancerGlobeNewsWire • 03/14/22
Sanofi (SNY) Management Presents at Cowen 42nd Annual Healthcare Conference (Transcript)Seeking Alpha • 03/09/22
Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in haemophilia A, demonstrating superiority to prior factor prophylaxis treatmentPRNewsWire • 03/09/22
Sanofi recognized by S&P as one of the most sustainability-committed companiesGlobeNewsWire • 03/08/22
GlaxoSmithKline and Sanofi plan to submit data from COVID-19 booster and Phase III trials for approvalProactive Investors • 02/23/22
Dow Jones Newswires: Sanofi, GSK to seek approval for Covid-19 vaccine after positive trial resultsMarket Watch • 02/23/22
Sanofi's Board of Directors proposes the appointment of Carole Ferrand, Emile Voest and Antoine Yver as independent DirectorsGlobeNewsWire • 02/22/22
Sanofi - Regeneron's Dupixent Under FDA Priority Review For Children Under 5 Years With Atopic DermatitisBenzinga • 02/10/22